- Interventional Radiology Treatments For Recurrent Prostate Cancer
© MedicalNewsToday.com
The first known patient cases using magnetic resonance-guided heat (laser interstitial thermal therapy) or cold (cryoablation) to treat prostate cancer recurrence after surgical removal of the prostate gland were presented by physicians at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa...
- Therapeutic Potential Of Adult Bone Marrow-Derived Mesenchymal Stem Cells In Prostate Cancer Bone Metastasis
© MedicalNewsToday.com
UroToday.com - Adult bone marrow-derived mesenchymal stem cells (MSC) have been shown to inhibit tumor growth in various studies. Although MSC express MHC class I molecules, they lack expression of co-stimulatory molecules and suppress T-cell response, which gives them the utility to overcome a wide range of immunologic barriers...
- RNA Quality In Fresh Frozen Prostate Tissue From Patients Operated With Radical Prostatectomy
© MedicalNewsToday.com
UroToday.com - Discovery of new genes that may be biomarkers for prostate cancer (CaP) often are identified by microarray analysis of RNA obtained from radical prostatectomy tissue. In the Scandinavian Journal of Clinical and Laboratory Investigation, Dr. Helena Bertilsson and colleagues analyze what variables impact RNA quality and ultimately lead to the discovery of biomarkers from CaP tissue...
- Transurethral Resection Of The Prostate In Saline Versus Nonconductive Solution To Treat Benign Prostatic Hyperplasia: A Randomized Controlled Study
© MedicalNewsToday.com
UroToday.com - For many decades, transurethral resection of the prostate (TURP) has been considered the benchmark of surgical management for BPH. The ideal irrigant for TURP would be a nonconductive medium that does not interfere with diathermy, has a high degree of translucency, has osmolality similar to that of serum, and causes only minimal side effects when absorbed. Traditionally, a 1...
- Benign Prostatic Hyperplasia: Symptoms, Symptom Scores, And Outcome Measures
© MedicalNewsToday.com
UroToday.com - Our chapter on BPH in the recent Urologic Clinics of North America focuses on improved methods for defining the etiology of lower urinary tract symptoms (LUTS)...
- A Randomized Trial Of Photoselective Vaporization Of The Prostate Using The 80-W Potassium-titanyl-phosphate Laser Vs. Transurethral Prostatectomy
© MedicalNewsToday.com
UroToday.com - The treatment of lower urinary tract symptoms (LUTS) secondary to bladder outlet obstruction (BOO) makes up a significant amount of the workload of most urologists...
- Genentech Provides Update On Phase III Study Of Avastin In Men With Late Stage Prostate Cancer
© MedicalNewsToday.com
Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today the topline results of a Phase III trial led by the U.S...
- Researchers Develop Tool To Help Study Prostate Cancer
© MedicalNewsToday.com
Van Andel Research Institute (VARI) researchers have developed a new method to better study the cells that line and protect the prostate in relation to the development of cancer. Using the model, they found that normal cells and cancer cells depend on different factors to survive, which could aid in discovering how to target cancer cells without affecting normal cells when developing treatments...
- New Way To Get Physical In The Fight Against Cancer
© MedicalNewsToday.com
Conventional biological wisdom holds that living cells interact with their environment through an elaborate network of chemical signals. As a result many therapies for the treatment of cancer and other diseases in which cell behavior goes awry focus on drugs that block or disrupt harmful chemical signals...
- Abbott Seeks FDA Approval Of A New Six-Month 45-mg Formulation Of Lupron(R) Depot For The Palliative Treatment Of Advanced Prostate Cancer
© MedicalNewsToday.com
The U.S. Food and Drug Administration (FDA) has accepted for review the supplemental new drug application (sNDA) of a new six-month 45-mg formulation of Lupron® Depot (leuprolide acetate for depot suspension) for use in the palliative treatment of advanced prostate cancer. Palliative treatment helps to relieve symptoms associated with advanced prostate cancer...
